Prevention in Lupus and Therapeutic Evolution in Sjögren’s explores the proactive approach in autoimmune diseases, mo https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/19/2026 […]
A Modern Approach to Osteoporosis Management am.castro222@g… Thu, 02/19/2026 – 08:00
RT @richardPAConway Target trial emulation from Dr Sparks group in RA-ILD. Abatatacept and JAKi seem to be better than https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RT @richardPAConway Data from Scott Matson’s group showing that immunosuppressing RA-ILD (agnostic to agent) results in https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 02/18/2026
Comorbidity & Health Management https://t.co/cSwCEDKL28 https://t.co/WP7yIdWPVY https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 02/18/2026 – 15:00 RheumNow Dr. John Cush Comorbidity & Health Management
Disease Modification, Disparities and the Next Therapeutic Frontier in Gout Gout management has entered what Dr. Rober https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
Together PSO Trial – Combination Ixekizumab and Tirzepatide jjcush@gmail.com Wed, 02/18/2026 – 12:24
Dermatomyositis outcomes w/ 2475 pts (claims) & 1196 pts (EHR). Half had myositis panels & 35% had + MSAbs. Ster
UK Biobank registry analyzed assoc. betw sleep duration, insomnia, & shift with osteoarthritis endpoints (KOA, HOA, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 02/18/2026
J Rheum full read editorial on What HLA-B27 Can—and Cannot—Tell Us!. HLA-B27 also holds prognostic and theragnostic https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,
Paradoxical Reactions, Target Selection & the Future of Imaging in Psoriatic Care gibsonab@hotmail.com Wed, 02/18/2026 – 08:00
Can I Use JAK Inhibitors During Pregnancy? jjcush@gmail.com Wed, 02/18/2026 – 07:00
RT @richardPAConway The new kid on the block in RA-ILD (and other PPF). Nerandomilast, an anti-fibrotic with additional https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RT @RichardPAConway ACR/Chest and EULAR/ERS guidelines for RA-ILD presented by Dr Sparks. I’m posting the one I use 😉 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RT @ericdeinMD #RNL26 Paradoxical psoriasis with TNF Highest in infliximab Seen highest in IBD, particular Crohn’s Pal https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue,
RT @ericdeinMD #RNL26 Prosthetic joint infection vs flare? – PJI risk 50-80% higher in RA (OR 1.47-1.8) – Immunosuppres https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
What did you miss at RheumNow Live 2026? Our Poster Hall features new data across: • Psoriatic Arthritis • Systemic
Spectrum of skin Sxs in 518 pts w/ Stills dz from AutoInflammatory Dz Alliance (AIDA) Network Registry dedicated to Stil
FDA has Changed labels for 6 Menopausal Hormone Therapies (HRT) removing black box warnings for CV dz, breast CA, &
Prevention in Lupus and Therapeutic Evolution in Sjögren’s gibsonab@hotmail.com Tue, 02/17/2026 – 13:24
RNL 26 Report: Rheumatoid Arthritis Audrey Gibson, PA-C, reports from RheumNow Live 2026 in Dallas, Texas, about the s https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Maui Potpourri (2.13.2026) Dr. Jack Cush reviews the hot item takeaways from last week’s RheumNow Live 2026. https:// https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RT @gibson_rheumPAC Given rising resistance, effective first-line regimens and adequate duration (14 days) are critical https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 02/17/2026 –
What’s New in Spondyloarthritis robertbchao@gm… Tue, 02/17/2026 – 08:14
RT @gibson_rheumPAC Who should be tested? Test only if you plan to treat. Indications include: • Active or prior ulce
Genentech announced results of Phase III, MAJESTY OL study of obinutuzumab vs tacrolimus in 142 pts w/ primary membranou https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Rotator cuff abnormalities are nearly universal after age 40, & incr w/ age; routine imaging should not guide Dz or
